Product updates, patent developments, and practical analysis. Explore the topics that matter to your work.
Subscribe via RSS
IP Insights
Eudia’s $105M Series A funding and acquisition of ALSP Out-House indicate a structural shift from selling legal software to operating AI-native legal services. This vertical integration resolves traditional SaaS adoption bottlenecks and creates a new competitive framework for intellectual property and legal operations.
IP News
As ToolGen secures key CRISPR-Cas9 RNP patents in the US and Europe, the decade-long battle over gene editing supremacy enters a high-stakes phase involving the Unified Patent Court (UPC) and billion-dollar royalties.
IP News
The landmark settlement between Moderna and Arbutus Biopharma over LNP delivery technology marks a historic turning point for the biotech industry, establishing the highest valuation yet for mRNA platform IP.
Market Intelligence
Harvey's $200 million financing round at an $11 billion valuation highlights a structural transition in the legal technology sector. As capital consolidates around vertical, agentic AI platforms, the intellectual property market faces a mandate to shift from isolated generative tools to integrated, stateful enterprise workflows.
IP Insights
As of 2025, China controls 70% of global AI patent filings. This report analyzes the operational risks for Western IP counsel, specifically regarding prior art blindness, the 'Subsidy Cliff,' and the necessity of AI-augmented search protocols.
Market Intelligence
An analysis of the 'Fatal Asteroid' scenario facing patent prosecution in late 2025. This brief examines how boutique firms can use AI-driven efficiency to dismantle the traditional billable hour model and undercut major firms through fixed-fee, high-margin service bundling.
IP News
The PTAB has ruled that foreign sovereign entities do not qualify as 'persons' under the AIA, effectively barring state-owned enterprises from filing IPR petitions against US patents. This decision creates a significant procedural barrier for state-linked competitors and shifts the primary battlefield for patent invalidity to federal courts.
IP Insights
With Legora securing a $5B+ valuation merely months after Harvey’s $11B benchmark, the legal AI market is rapidly consolidating into a transatlantic duopoly. This analysis examines the capital-intensive moat being built around enterprise legal intelligence and the shrinking viability of uncapitalized point solutions.
IP Insights
Lawhive’s $60M Series B validation signals a divergence in the legal AI market: while Harvey and Legora compete for enterprise SaaS dominance, the "full-stack" model is beginning to disrupt the service delivery layer itself.
IP News
The entry of ToolGen into the high-stakes CRISPR patent battle against Vertex and CRISPR Therapeutics signals a new era of multi-jurisdictional litigation in gene editing.
IP News
As ToolGen secures key CRISPR-Cas9 RNP patents in the US and Europe, the gene-editing licensing picture shifts, signaling a high-stakes showdown at the Unified Patent Court.
Market Intelligence
<strong>Legora's</strong> acquisition of agentic AI startup <strong>Walter AI</strong>, executed just days after a $550 million capital injection, signals a structural evolution in the legal technology sector. Alongside <strong>Harvey's</strong> recent acquisition of <strong>Lume</strong>, these moves indicate a definitive shift from isolated generative models toward integrated, multi-agent enterprise infrastructure.
